Author: Manojna Maddipatla
-
UnitedHealth says Omicron-driven cost impact cushioned by healthcare deferrals
By Manojna Maddipatla (Reuters) -UnitedHealth Group Inc on Wednesday said added costs of testing and treatment related to the recent surge in COVID-19 cases are being offset by postponements of non-urgent healthcare procedures, and the health insurer maintained its 2022 profit forecast. The comments should help allay investor concerns that the steep rise in COVID…
-
Pfizer to supply U.S. with 10 million more courses of COVID-19 pills
WASHINGTON • The Biden administration doubled its order for Pfizer Inc’s oral COVID-19 antiviral treatment, the company and the White House said Tuesday, providing the government 20 million courses as it fights a record surge in COVID-19 cases. The White House now expects about 4 million treatment courses of the pills to be available by…